Novo Nordisk Rybelsus 3 mg Semaglutide Tablets
Rybelsus (semaglutide) 3 mg is a prescription oral glucagon-like peptide-1 (GLP-1) receptor agonist formulated to improve glycemic control in adults with type 2 diabetes when used alongside diet and exercise.Mechanism of ActionRybelsus functions similarly to natural incretin hormones in the body. It stimulates insulin secretion in response to elevated blood sugar levels, decreases glucagon product
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
Rybelsus (semaglutide) 3 mg is a prescription oral glucagon-like peptide-1 (GLP-1) receptor agonist formulated to improve glycemic control in adults with type 2 diabetes when used alongside diet and exercise.
Mechanism of Action
Rybelsus functions similarly to natural incretin hormones in the body. It stimulates insulin secretion in response to elevated blood sugar levels, decreases glucagon production from the liver, and slows gastric emptying to aid in blood sugar regulation.
Administration Instructions
- Take once daily at least 30 minutes before the first meal, beverage, or other oral medications of the day.
- Swallow the tablet whole with no more than 4 fl oz of plain water. Do not chew, crush, or split the tablet.
Storage
Store at room temperature in the original container, protected from direct light and moisture.
| Brand | Novo Nordisk |
| Active Ingredient | Semaglutide |
| Strength | 3 mg |
| Drug Class | Glucagon-like peptide-1 (GLP-1) receptor agonist |
| Form | Tablet |
| Indication | Type 2 Diabetes |
| Manufacturer | Novo Nordisk |
| Packaging | 10 Tablets in 1 strip |
| Brand | Novo Nordisk |
|---|








Reviews
There are no reviews yet.